(Q57154153)

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Anti-obesity drugs: a review about their effects and their safety

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Bariatric surgery for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Bariatric surgery: an IDF statement for obese Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Metabolic/bariatric surgery worldwide 2011.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Metabolic surgery: an evolution through bariatric animal models

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

How do we define cure of diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Bariatric surgery versus conventional medical therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The mechanism of weight loss with laparoscopic adjustable gastric banding: induction of satiety not restriction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The mechanisms of weight loss after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Gastric emptying is not affected by sleeve gastrectomy--scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Is the Roux limb a determinant for meal size after gastric bypass surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Gastric bypass and banding equally improve insulin sensitivity and β cell function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Relative changes in resting energy expenditure during weight loss: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Body composition and energy expenditure after weight loss following bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Gastric bypass increases energy expenditure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Mechanisms underlying weight loss after bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Eating behavior and the experience of hunger following gastric bypass surgery for morbid obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The effect of vertical sleeve gastrectomy on food choice in rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Selective reduction in neural responses to high calorie foods following gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Increased hepatic insulin clearance after Roux-en-Y gastric bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Molecular physiology of weight regulation in mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Are bile acids the new gut hormones? Lessons from weight loss surgery models

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The importance of the gut microbiota after bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The human gut microbiome: a review of the effect of obesity and surgically induced weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The gut and energy balance: visceral allies in the obesity wars

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The regulation of food intake by the gut-brain axis: implications for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

My brain made me do it, and my gut didn't help.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Weight loss after gastric bypass is associated with a variant at 15q26.1.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970218-3

7 January 2021